Cingulate Inc. (NASDAQ: CING) Stock Information | RedChip

Cingulate Inc. (NASDAQ: CING)


$4.2200
+0.1200 ( +1.20% ) 28.7K

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

Market Data


Open


$4.2200

Previous close


$4.1000

Volume


28.7K

Market cap


$13.17M

Day range


$4.1300 - $4.3900

52 week range


$1.8001 - $152.4000

SEC Filings


Form Type Description Pages Date
8-k 8K-related 18 Dec 23, 2024
10-q Quarterly Reports 64 Nov 07, 2024
8-k 8K-related 15 Nov 07, 2024
8-k 8K-related 16 Oct 15, 2024
8-k 8K-related 15 Oct 07, 2024
8-k 8K-related 14 Oct 04, 2024
4 Insider transactions 1 Oct 01, 2024
4 Insider transactions 1 Oct 01, 2024
8-k 8K-related 15 Sep 12, 2024
8-k 8K-related 14 Sep 10, 2024

Latest News